ACR updates Appropriateness Criteria

| | Health Imaging | Screening

The American College of Radiology (ACR) has updated evidence-based guidelines to help healthcare providers choose the most appropriate medical imaging exam or radiation therapy for a patient’s clinical condition via the latest version of its Appropriateness Criteria.

In the latest version, the ACR updated 23 appropriateness criteria topics and added four new criteria—Pulmonary Hypertension; Renal Transplant Dysfunction; Management of Locoregionally Advanced Squamous Cell Carcinoma of the Vulva; and Treatment of Stage I T1 Glottic Cancer. ACR Appropriateness Criteria guide physicians when ordering exams and help ensure that patients get the right scan or therapy for the right indication. The criteria have been shown to improve quality, reduce unnecessary exams and lower costs, according to the ACR. 

ACR Appropriateness Criteria provide a tool for more effective clinical decision making to help ensure that imaging is neither over- nor underutilized. The guidelines are developed by expert panels in diagnostic imaging, interventional radiology and radiation oncology. Each panel includes leaders in radiology and other specialties.

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.